Introduction

Chronic lymphocytic leukemia (CLL) is a monoclonal proliferation of CD5
+ B cells that usually affects middle-aged and elderly patients (reviewed in Ref. 1) . Although, CLL is a typically low-grade, clinically indolent neoplasm that is stable over several years, approximately 5-10% of cases progress to diffuse large B cell lymphoma (DLBL). This process is commonly referred to as Richter's syndrome or transformation. Richter's transformation is usually accompanied by progressive lymphadenomegaly, marked clinical progression of the disease, and shorter survival (reviewed in Ref. 2) .
The molecular mechanism(s) of clinical progression and morphologic transformation of CLL from low-to high-grade disease has not been elucidated yet, although some secondary genetic abnormalities at both the nucleic acid and chromosomal level have been documented in Richter's transformation (reviewed in Refs 3 and 4). Different chromosomal defects, [5] [6] [7] deletion of retinoblastoma 8 and p16/INK4A, 9 mutations of the p53 tumor suppressor gene, 10, 11 increased copy number of C-MYC, 12 and decreased expression of A-MYB gene 13 may be associated with Richter's transformation of CLL, but none of these aberrations seems to be a predominant genetic lesion Several lines of evidence suggest that genomic instability may be involved in tumor development and progression. Genetic instability can be the result of inactivation of the tumor suppressor genes, or may manifest at the level of nucleotide sequence as errors in DNA replication, usually detected as alterations in the length of short repetitive sequences (microsatellites). Microsatellite instability (MSI) is frequently associated with the inactivation of DNA mismatch repairs resulting from inherited mutations or promoter hypermethylation of the DNA mismatch repair genes (reviewed in Refs 14 and 15) .
To analyze whether Richter's transformation of CLL is associated with genomic instability, we have performed longitudinal microsatellite analysis in sequential biopsy specimens from patients with CLL that showed no histologic alterations in subsequent biopsy specimens or underwent morphologic transformation to DLBL. We have also analyzed the nucleic acid sequences of the hMLH1 and hMSH2 genes and hypermethylation of the hMLH1 promoter to reveal whether DNA mismatch repair defects are associated with the Richter's transformation of CLL. Our results indicate that MSI and hypermethylation of the hMLH1 gene are frequently associated with Richter's transformation of CLL.
Materials and methods
Pathological samples and DNA extraction
Sequential biopsy samples of 19 patients with CLL observed at 1st Department of Pathology and Experimental Cancer Research, Faculty of Medicine, Semmelweis University were selected for this study based on the availability of frozen tissue for the molecular analyses. Diagnoses were based on histopathologic, immunophenotypic and immunogenotypic analyses according to the World Health Organization Classification of lymphoid tissues. 16 In 10 patients (cases 1-10), the histology of the second biopsy was identical with the first biopsy. In nine patients (cases [11] [12] [13] [14] [15] [16] [17] [18] [19] , histology of the second biopsy was classified as DLBL (Table 1) . Genomic DNAs were extracted from cryopreserved blood or tissue samples, using the salting out technique. 17 
Analysis of clonal relationship of the first and second biopsy samples
To determine clonal relationship of the first and second biopsy samples, complementary determining region 3 (CDR3) of the immunoglobulin heavy chain (IgH) was analyzed. The poly- merase chain reaction (PCR) amplification of the CDR3 sequences was carried out using the FR3 sense primer in conjunction with the J H consensus antisense primer as described before. 18 
Analysis of microsatellite instability
Eight microsatellite repeat markers mapping to different chromosomes were studied, including five dinucleotide repeats (DCC, D6S262, D3S1262, D3S1261, MYC), one trinucleotide repeat (AR), and two tetranucleotide repeats (ACTBP2, FGA). Each microsatellite repeat was amplified by PCR. Primers were synthesized based on sequences derived from the Genome Data Bank (GDB, Baltimore, MD, USA) by Integrated DNA Technologies (Coralville, IA, USA). PCR reactions were performed in a final volume of 10 l containing 100 ng of DNA template, 1 to 2 mmol/l MgCl 2 , 10 pmol of each primer, 2.5 mol/l dNTPs, 1 Ci of [␣-32 P] dCTP, 0.5 U Taq polymerase. Thirty-five cycles consisting of denaturation (30 s at 94°C), annealing (annealing temperatures were optimized for each pair of primers) and extension (30 s at 72°C) using a Perkin-Elmer 2400 GeneAmp PCR system were performed. Annealing temperatures were 55°C for D3S1261, DCC, MYC; 58°C for ACTBP2, FGA, D6S262, D3S1262; 62°C for AR. PCR products were separated by electrophoresis in 6% polyacrylamide-TBE denaturing gels for 2 to 4 h at 70 W. Gels were fixed in 10% acetic acid, air dried, and exposed to X-ray films at −70°C.
Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis of the hMLH1 and hMSH2 genes
PCR-SSCP analysis of the hMLH1 gene was performed on five exons (exons 9, 11, 14, 15 and 16). The selection of these exons for the mutational analysis of hMLH1 gene was based on the evidence that mutations of these sequences had been described in previous reports. 19, 20 The PCR-SSCP analysis of the hMSH2 gene was performed on nucleotide positions 2020-2225 of the cDNA and the flanking regions of the genomic DNA containing the intron/exon junctions. 21 The PCR-SSCP analysis of the hMLH1 and hMSH2 genes was performed as described previously.
19,21
Analysis of the hMLH1 promoter methylation
Genomic DNA samples were analyzed for the presence of hypermethylation at CpG sites in the promoter region of hMLH1 gene from codon −670 to −67 using PCR-based HpaII restriction enzyme assay as detailed previously. 22 This gene sequence contains HpaII and MspI restriction sites at nucleotide positions −567, −527, −347 and −341. DNAs were digested with HpaII (New England Biolabs, Beverly, MA, USA) or MspI (New England Biolabs) restriction endonucleases. Digested and undigested DNAs were PCR amplified using primer pairs (MLH1-27494: CGCTGCTAGTATTCGTGC and MLH1-25266: TCAGTGCCTCGTGCTCAC), electrophoretically separated in 1% agarose gels, stained with ethidium bromide, and visualized under UV illumination. Unmethylated and methylated controls were included in all reactions.
Results
Clonal relationship of the first and second biopsy samples
All samples included in this study displayed monoclonal IgH gene rearrangement. In each case, the first and the corresponding second biopsy samples showed identical IgH gene rearrangements indicating the common clonal origin of the tumor samples.
Microsatellite analysis
In each case, the samples of the first and second biopsies were evaluated in parallel using eight microsatellite markers. A locus was considered positive when the electrophoretic migration pattern differed in DNA from the first compared with DNA from second biopsy samples. MSI was evident when DNA of second biopsy sample displayed one or more new bands compared with the first biopsy sample. Loss of heterozygosity (LOH) was considered positive if bands of the first Microsatellite alterations detected in 19 patients with CLL that showed no histologic alterations in subsequent biopsy specimens (cases 1-10) or underwent morphologic transformation to DLBL (cases [11] [12] [13] [14] [15] [16] [17] [18] [19] . Status of each microsatellite locus is indicated as follows: white box, retention of heterozygosity; black box, loss of heterozygosity; gray box, microsatellite instability. Markers are listed at the top of each column.
biopsy sample were lost in the second biopsy sample. The results of the microsatellite analysis are summarized in Figure 1 and representative cases are illustrated in Figure 2 . In the 10 patients with CLL that showed no histological alteration in the subsequent biopsy sample, a total of five microsatellite differences were found between the first and second biopsy samples. MSI was detected in four and LOH was found in one microsatellite loci. In three cases (cases 2, 3 and 9) a single and in one case (case 1) two loci showed alterations. In the nine patients with CLL transformed to DLBL, the eight microsatellite loci displayed a total of 28 differences between the CLL and transformed DLBL samples. MSI was detected in 19 and LOH was found in nine microsatellite loci. In one case (case 15) a single, in two cases (cases 12 and 14) three, in one case (case 13) four, in another case (case 18) five, and in two cases (cases 11 and 19) six microsatellite loci showed alterations. In two cases (cases 16 and 17), the patterns of the microsatellites were identical in CLL and transformed DLBL samples. However, it could not be established whether microsatellite alteration had already occurred at the initial CLL stage of the disease or had developed only during tumor progression, since non-neoplastic control DNAs were not available in these cases.
PCR-SSCP analysis of the hMLH1 and hMSH2 genes
PCR-SSCP analysis of hMLH1 and hMLH2 genes was performed in 19 cases. In each case, the samples of the first and second biopsies were evaluated simultaneously. The PCR-
Figure 2
Representative results of microsatellite analysis of paired serial biopsy specimens of CLL and transformed DLBL samples in case 19.
Leukemia SSCP analysis revealed normally migrating bands exclusively, suggesting that nucleotide alterations of the hMLH1 and hMLH2 genes had not occurred in CLL or transformed DLBL cells (results are not shown).
Analysis of the hMLH1 promoter methylation
To evaluate the methylation of CpG sites in the hMLH1 promoter, PCR products amplified from undegested, HpaII and MshI digested DNAs were evaluated in parallel. In each case, the results of hMLH1 promoter methylation of the first and second biopsy samples were compared. The results are summarized in Table 2 and representative samples are illustrated in Figure 3 . In all samples, the PCR amplification of undigested DNAs resulted in a 604 nucleotide long DNA fragment. In five samples of CLL and corresponding samples of DLBL (cases 11-13, 18 and 19) the hMLH1 promoter region was resistant to digestion by HpaII and sensitive to digestion by MspI. In all 10 cases of CLL that showed no histologic alteration in the second biopsy, and in four cases of CLL and subsequent DLBLs (cases 1-10 and 14-17), the hMLH1 promoter region was sensitive to digestion by both HpaII and MspI. These data are consistent with methylation at CpG sites at HpaII and MspI sites between −670 and −67 of the hMLH1 Table 2 Methylation status of hMLH1 promoter in 19 patients with CLL that showed no histologic alterations in subsequent biopsy specimens or underwent morphologic transformation to DLBL
Patient
Sample
CLL, chronic lymphocytic leukemia; DLBL, diffuse large B cell lymphoma; +, hypermethylated; −, unmethylated.
Figure 3
Representative methylation analysis of CpG islands in hMLH1 promoter in CLL and transformed DLBL samples of case 12. U, undigested DNA samples; H, DNA digested with HpaII enzyme; M, DNA digested with MspI enzyme.
promoter region in CLL and transformed DLBL samples of cases 11-13, 18 and 19 and unmethylation in cases 1-10 and 14-17).
Discussion
To determine whether MSI characterizes the histological transformation of CLL and to investigate the contribution of the mutator pathway to lymphoma progression, we evaluated CLLs and clonally related DLBLs in nine cases of Richter's syndrome for microsatellite alteration. We have also analyzed 10 cases of CLL that showed no histological transformation in the subsequent biopsy sample. A thorough analysis with a panel of eight microsatellite markers rewealed MSI in three cases of CLL that showed no histologic alteration and in seven cases of CLL transformed to DLBL. MSI ranged from one to two in CLLs without transformation and one to four in transformed cases. For colorectal cancers, high level of MSI (MSI-H) and low-level of MSI (MSI-L) have been defined when more than 30-40% and less than 30-40% of microsatellite markers are unstable, respectively. 23 Using this definition four cases of Richter's transformation associated with MSI-H, but none of the CLLs, reached this level of MSI without histologic transformation. However, it has been reported that MSI is rather rare in B cell lymphomas, [24] [25] [26] as a subset of B cell CLL may express mutator phenotype. 25 Our study provides evidence that MSI may occur in the clinical course of CLL, but this phenomenon is rather a late event that contributes to the transition from low-to high-grade disease than initiates the primary disease. Our observations were consistent with other studies in that MSI frequently develops during tumor progression in hemopoietic neoplasms, including blastic transformation of chronic myeloid leukemia, histologic transformation of follicular and MALT lymphoma. [27] [28] [29] A distinct form of genomic instability is the result of inactivation of tumor suppressor genes, which may manifest as LOH. In five cases of Richter's transformation a total of nine microsatellite loci showed LOH. In contrast to this findings, only one case of CLL without histologic transformation developed LOH in a single microsatelite locus indicating that DNA imbalances may also contribute to the lymphoma progression and Richter's transformation. Interestingly, several microsatellite loci showed LOH in Richter's transformation but predominantly effected loci were not detected. The heterogeneous distribution of LOH suggests that an imbalance among several genes rather than a single specific gene locus is responsible for the transformation of CLL. This hypothesis is also supported by the recent findings of comparative genomic hybridization (CGH) analysis of progressed CLLs, where DNA losses affected different chromosomes including chromosomes 13, 17p, 8p, 11q and 14q in DLBLs transformed from CLLs. 30 Close correlation between MSI and structural alteration of DNA repair genes has been reported in hereditary and sporadic solid tumors. 20, 21 To analyze whether MSI found in follow-up of CLLs and Richter's transformation is associated with genetic or epigenetic inactivation of DNA repair genes, we have studied the most frequently mutated exons of the hMLH1 and hMSH2 mismatch repairs genes for mutations, and the promoter region of the hMLH1 gene for hypermethylation. No structural alterations were found in coding regions of hMLH1 and hMSH2 genes, but hMLH1 promoter was hypermethylated in both CLLs and clonally related transformed DLBLs in five cases. CLLs without histologic alterations displayed no hMLH1 promoter hypermethylation. Whether hMLH1 promoter hypermethylation in CLL and transformed DLBLs is a specific event in lymphoma transformation or a simple consequence of a global hypermethylation activity is highly questionable. Indeed, hypermethylation of EphA3, p15
INK4a , p73, and DAP-kinase genes have also been described in lymphomas and leukemias suggesting a more global increased methylation activity in hematopoietic neoplasms. 9, [31] [32] [33] [34] Several lines of evidence suggest that DNA methylation begins at the earliest stage of the neoplastic process and changes in DNA methylation is a vital aspect of tumor progression. 34 This hypothesis is supported by the findings that hMLH1 promoter hypermethylation occurs in early endometrial, colorectal and gastric cancer before the propagation of the tumor cells. 36, 37 The hypermethyation of hMLH1 promoter in both the indolent CLL and the transformed DLBL suggest that this alteration may occur early in the development or clonal evolution of certain cases of CLL. In four of the five cases, where hMLH1 promoter was hypermethylated in both CLL and DLBL, the transformed DLBL cells displayed MSI-H compared with their corresponding CLL samples. Although, nonneoplastic tissue samples of these patients were not available in this retrospective study to analyze whether microsatellite instability had already occurred before the transformation of the CLL, our results suggest that MSI is initiated in those transformed cases where hMLH1 promoter was hypermethylated.
In light of the MSI, LOH and the hypermethylation of the hMLH1 promoter detected in this study, it seems that multiple pathways of oncogenesis may play a role in the tumor progression and Richter's transformation of CLLs. In these processes the hypermethylaton of hMLH1 promoter in CLL and the development of MSI in the subsequent DLBL is one of the pathways which may play a role in the development of certain cases of Richter's syndrome.
